BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Carna Biosciences Signs Distribution Agreements To Expand Businesses In Europe


8/4/2006 10:47:53 AM

KOBE, Japan, Aug. 4 /PRNewswire/ -- Carna Biosciences, Inc. has signed agreements with Bio-Connect BV and KinaseDetect ApS and appointed them distributors in which Carna Biosciences has granted Bio-Connect exclusive rights to sell protein kinases in Germany, the United Kingdom, France, The Netherlands, Belgium and Luxembourg, and has granted KinaseDetect exclusive rights to sell protein kinases in the Scandinavian countries (Denmark, Sweden, Norway and Finland).

Utilizing proprietary technologies and know-how on gene cloning, active protein expression and protein purification, Carna Biosciences has succeeded in producing more than 240 protein kinases. Pure and highly active kinases are prerequisite for pharmaceutical companies developing kinase inhibitors whose compounds are in lead finding to lead optimization processes.

"Signing agreements with Bio-Connect and KinaseDetect is our major step forward in our quest to be recognized as a 'Kinase company' in European countries. With powerful marketing and sales channels which Bio-Connect and KinaseDetect have established, we are able to quickly expand sales of protein kinases in the region. The protein kinases will be available from September through the distributors," said Kohichiro Yoshino, President and CEO of Carna Biosciences. "I am confident in our continuing ability to provide reliable protein kinases of the highest quality."

About Carna Biosciences

Carna Biosciences, Inc. (http://www.carnabio.com), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, as well as providing drug discovery services to pharmaceutical companies, with proprietary technologies in gene cloning, active kinase protein expression, protein purification and homogeneous assay development. The company provides products and services including protein kinases, profiling and screening services, assay development services and crystallography products and services.

Contact: Kyoko Omoda, Manager Corporate Planning Carna Biosciences, Inc. Phone: +81-78-302-7039 Fax: +81-78-302-7086 E-mail: marcom@carnabio.com URL: http://www.carnabio.com

Carna Biosciences, Inc.

CONTACT: Kyoko Omoda, Manager, Corporate Planning of Carna Biosciences,Inc., +81-78-302-7039, or Fax: +81-78-302-7086



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES